High discordance between pre-US and post-US entry tuberculosis test results among immigrant children: Is it time to adopt interferon gamma release assay for preentry tuberculosis screening?

Pediatric Infectious Disease Journal

Volumn 35, Issue 3, 2016, Pages 231-236

  Lowenthal, Phil ^a   Barry, Pennan M ^a   Flood, Jennifer ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Children; Immigration screening; Tuberculosis

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHINA; FEMALE; HUMAN; IMMIGRANT; INTERFERON GAMMA RELEASE ASSAY; MAJOR CLINICAL STUDY; MALE; MEXICO; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; CALIFORNIA; HEALTH SURVEY; MASS SCREENING; MIGRANT; PROCEDURES;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; POPULATION SURVEILLANCE; REGISTRIES; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84959252012     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000986     Document Type: Article

References (30)

1. Alami NN, Yuen CM, Miramontes R, et al; Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63:229-233.
2. Tuberculosis Control Branch. Report on Tuberculosis in California, 2013. Richmond, CA: California Department of Public Health; July 2014.
3. Monger R, Yankay J. Annual Flow Report U.S. Legal Permanent Residents: 2012. Available at: https://www.dhs.gov/sites/default/files/publications/ois-lpr-fr-2012-2.pdf. Accessed July 17, 2013 and July 10, 2014.
4. Tuberculosis Profiles by County. WHO Stop TB Partnership 2014. Available at: http://www.stoptb.org/countries/tbdata.asp. Accessed August 12, 2014.
5. Hill AN, Becerra J, Castro KG. Modelling tuberculosis trends in the USA. Epidemiol Infect. 2012;140:1862-1872.
6. Centers for Disease Control and Prevention. CDC Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment. 2009. Available at: http://www.cdc.gov/immigrantrefugeehealth/pdf/tuberculosis-ti-2009.pdf. Accessed June 15, 2014.
7. Bianchi L, Galli L, Moriondo M, et al. Interferon-gamma release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J. 2009;28:510-514.
8. World Health Organization. bacille Calmette-Guérin vaccine. Reported Estimates of BCG Coverage. Available at: http://apps.who.int/immunization-monitoring/globalsummary/timeseries/tscoveragebcg.html. Accessed August 2, 2013.
9. Carvalho AC, Pezzoli MC, El-Hamad I, et al. Quanti FERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect. 2007;55:164-168.
10. Winje BA, Oftung F, Korsvold GE, et al. Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of Quanti FERON TB Gold with tuberculin skin test. BMC Infect Dis. 2008;8:65.
11. Painter JA, Graviss EA, Hai HH, et al. Tuberculosis screening by tuberculosis skin test or Quanti FERON-TB Gold In-Tube assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination. PLoS One. 2013;8:e82727.
12. Bamford AR, Crook AM, Clark JE, et al. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child. 2010;95:180-186.
13. BCG Atlas. McGill University & McGill University Health Center, Public Health Agency of Canada. Available at: http://www.bcgatlas.org. Accessed June 10, 2014.
14. Lee D, Philen R, Wang Z, et al; Centers for Disease Control and Prevention. Disease surveillance among newly arriving refugees and immigrants-Electronic Disease Notification System, United States, 2009. MMWR Surveill Summ. 2013;62:1-20.
15. Guidelines for the Follow-up and Assessment Evaluation of Persons with Class A/B Tuberculosis. Available at: http://www.ctca.org/fileLibrary/file-375.pdf. Accessed June 8, 2015.
16. Orlando G, Merli S, Cordier L, et al. Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection. 2010;38:195-204.
17. Pareek M, Watson JP, Ormerod LP, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and costeffectiveness analysis. Lancet Infect Dis. 2011;11:435-444.
18. De Keyser E, De Keyser F, De Baets F. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belg. 2014;69:358-366.
19. Schopfer K, Rieder HL, Bodmer T, et al. The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis. Eur J Pediatr. 2014;173:331-336.
20. Herrera V, Perry S, Parsonnet J, et al. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011;52:1031-1037.
21. Howley M, Painter J, Katz D, et al. Evaluation of Quanti FERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection. Pediatr Infect Dis J. 2015;34:35-39.
22. Ritz N, Curtis N. Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb). 2009;89:248-251.
23. Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012.
24. Shanaube K, Hargreaves J, Fielding K, et al. Risk factors associated with positive Quanti FERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS One. 2011;6:e18206.
25. Pareek M, Bond M, Shorey J, et al. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis. Thorax. 2013;68:230-239.
26. Cain KP, Benoit SR, Winston CA, et al. Tuberculosis among foreign-born persons in the United States. JAMA. 2008;300:405-412.
27. Walter ND, Painter J, Parker M, et al; Tuberculosis Epidemiologic Studies Consortium. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med. 2014;189:88-95.
28. Red Book. Committee on Infectious Diseases; American Academy of Pediatrics. Available at: http://redbook.solutions.aap.org/chapter.aspx?s ectionId=56798384&bookId=886&resultClick=1#56806636. Accessed January 29, 2015.
29. Porco TC, Lewis B, Marseille E, et al. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health. 2006;6:157.
30. Linas BP, Wong AY, Freedberg KA, et al. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011;184:590-601.